Form 4 for FLUT Flutter Entertainment plc
Accepted 2025-03-10 00:00:00 ET · period of report 2025-03-04 · accession 0001628280-25-011766 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-10 | 2025-03-07 | FLUT | Coldrake Robert | CFO | M - OptEx | — | +350 | 350 | New | — |
| D | 2025-03-10 | 2025-03-07 | FLUT | Coldrake Robert | CFO | S - Sale+OE | $255.11 | -166 | 184 | -47% | -$42.3K |
| DM | 2025-03-10 | 2025-03-04 | FLUT | Coldrake Robert | CFO | D - Sale to Iss | — | -14.0K | 0 | -100% | — |
| D | 2025-03-10 | 2025-03-04 | FLUT | Coldrake Robert | CFO | A - Grant | — | +14.0K | 14.0K | New | — |
| D | 2025-03-10 | 2025-03-07 | FLUT | Coldrake Robert | CFO | M - OptEx | $0.00 | -350 | 13.6K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-03-07 | M | A | 350 | — | 350 | D | — | — | (F1) Represents ordinary shares of the Issuer acquired upon settlement of a restricted stock unit (RSU) award previously granted to the Reporting Person. |
| 2 | Common | Ordinary Shares | 2025-03-07 | S | D | 166 | $255.11 | 184 | D | — | — | (F2) The sales price reported herein was converted from British sterling pounds to United States dollars at a conversion price of GBP 1.00 to U.S. $1.29. |
| 3 | Derivative | Nil Cost Options (Right to Buy) | 2025-03-04 | D | D | 9,779 | — | 0 | D | $0.00 · — to 2032-12-30 | 9,779 Ordinary Shares | (F3) Reflects the conversion of Nil Cost Options to RSU awards subject to the same terms and conditions as the Nil Cost Options. No new grants were made in connection with these conversions. (F6) These options vest on March 2, 2026. |
| 4 | Derivative | Nil Cost Options (Right to Buy) | 2025-03-04 | D | D | 1,807 | — | 0 | D | $0.00 · — to 2033-03-07 | 1,807 Ordinary Shares | (F7) The number of options reported herein may be increased by up to 50% upon the achievement of certain performance criteria. (F3) Reflects the conversion of Nil Cost Options to RSU awards subject to the same terms and conditions as the Nil Cost Options. No new grants were made in connection with these conversions. (F8) These options vest on October 1, 2026 |
| 5 | Derivative | Restricted Stock Units | 2025-03-04 | A | A | 13,978 | — | 13,978 | D | — · — to — | 13,978 Ordinary Shares | (F3) Reflects the conversion of Nil Cost Options to RSU awards subject to the same terms and conditions as the Nil Cost Options. No new grants were made in connection with these conversions. (F10) Each RSU represents the contingent right to receive one ordinary share. (F11) These RSUs vest as follows: (a) 350 vest on March 7, 2025, (b) 544 vest in two equal annual instalments beginning on April 2, 2025, (c) 9,779 vest on March 2, 2026, (d) 1,807 vest on October 1, 2026, and (e) 1,498 vest on September 1, 2027. |
| 6 | Derivative | Restricted Stock Units | 2025-03-07 | M | D | 350 | $0.00 | 13,628 | D | — · — to — | 350 Ordinary Shares | (F10) Each RSU represents the contingent right to receive one ordinary share. (F12) These RSUs vested and settled into ordinary shares of the Issuer on March 7, 2025. The remainder of the RSUs vest on various dates through 2027. |
| 7 | Derivative | Nil Cost Options (Right to Buy) | 2025-03-04 | D | D | 544 | — | 0 | D | $0.00 · — to 2034-04-02 | 544 Ordinary Shares | (F3) Reflects the conversion of Nil Cost Options to RSU awards subject to the same terms and conditions as the Nil Cost Options. No new grants were made in connection with these conversions. (F5) These options vest in two equal annual installments beginning on April 2, 2025. |
| 8 | Derivative | Nil Cost Options (Right to Buy) | 2025-03-04 | D | D | 350 | — | 0 | D | $0.00 · — to 2033-03-07 | 350 Ordinary Shares | (F3) Reflects the conversion of Nil Cost Options to RSU awards subject to the same terms and conditions as the Nil Cost Options. No new grants were made in connection with these conversions. (F4) These options vest on March 7, 2025. |
| 9 | Derivative | Nil Cost Options (Right to Buy) | 2025-03-04 | D | D | 1,498 | — | 0 | D | $0.00 · — to 2034-04-02 | 1,498 Ordinary Shares | (F7) The number of options reported herein may be increased by up to 50% upon the achievement of certain performance criteria. (F3) Reflects the conversion of Nil Cost Options to RSU awards subject to the same terms and conditions as the Nil Cost Options. No new grants were made in connection with these conversions. (F9) These options vest on September 1, 2027. |